Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma

Mayo Clinic Proceedings

Volumn 77, Issue 5, 2002, Pages 437-445

  Meltzer, Eli O ^a   Lockey, Richard F ^b   Friedman, Bruce F ^c   Kalberg, Chris ^d   Goode Sellers , Stacey ^d   Srebro, Sharon ^d   Edwards, Lisa ^d   Rickard, Kathleen ^d  

^a ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Allergy Asthma Bronchitis and Immunology Associates   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

AQLQ = asthma quality of life questionnaire; MDI = metered dose inhaler; PEF = peak expiratory flow

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FLOVENT INHALATION AEROSOL; FLUTICASONE PROPIONATE; MONTELUKAST;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CANDIDIASIS; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HOARSENESS; HUMAN; INSOMNIA; LONG TERM CARE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SLEEP; SORE THROAT; UPPER RESPIRATORY TRACT INFECTION;

EID: 0036238064     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.5.437     Document Type: Article

References (35)

1. Forecasted state-specific estimates of self-reported asthma prevalence - United States, 1998
2. Surveillance for asthma-United States, 1960-1995
3. Trends in the cost of illness for asthma in the United States, 1985-1994
4. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma
5. Low-dose inhaled corticosteroids and the prevention of death from asthma
6. Inhaled steroids and the risk of hospitalization for asthma
7. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity
8. Montelukast a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: A multicenter, randomized, double-blind trial
9. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma
10. Zafirlukast for symptomatic mildto-moderate asthma: A 13-week multicenter study
11. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes
12. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? No
13. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
14. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: A randomized, controlled trial
15. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial
16. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma: This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986
17. Reference spirometric values using techniques and equipment that meet ATS recommendations
18. Determining a minimal important change in a disease-specific Quality of Life Questionnaire
19. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: A randomized double-blind, placebo-controlled trial
20. Fluticasone propionate versus zafirlukast: Effect in patients previously receiving inhaled corticosteroid therapy
21. Time to onset of effect of fluticasone propionate in patients with asthma
22. Montelukast added to inhaled beclomethasone in treatment of asthma
23. One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma
24. Asthma controller medications: What do patients want?
25. Airway mucosal inflammation even in patients with newly diagnosed asthma
26. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids
27. Efficacy and safety of inhaled corticosteroids: New developments
28. Effect of short-term treatment with 16w-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: A placebo-controlled study
29. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma
30. Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthma